References
- Grund FM, Armitage JO, Burns P. Hydroxyurea in the prevention of the effects of leukostasis in acute leukemia. Arch Intern Med 1977;137:1246–1247.
- Ferrara F, Annunziata M, Copia C, et al. Therapeutic options and treatment for patients over 75 years of age with acute myeloid leukemia. Haemotologica 1998;83:126–131.
- Camba L, Bernardi M, Pescarollo A. Complete haematological response with granulocyte colony stimulating factor (G-CSF) and hydroxyurea in relapsed acute myeloid leukaemia (AML) of the elderly. Haematologica 2001;86:E21.
- Petti MC, Tafuri A, Latagliata R, et al. High-dose hydroxyurea in the treatment of poor-risk myeloid leukemias. Ann Hematol 2003;82: 476–480.
- Hicsonmez G. The effect of steroid on myeloid leukemic cells: the potential of short-course high-dose methylprednisolone treatment in inducing differentiation, apoptosis and in stimulating myelopoiesis. Leuk Res 2006;30:60–68.
- Beekman R, Touw IP. G-CSF and its receptor in myeloid malignancy. Blood 2010;115:5131–5136.
- Lowenberg B, van Putten W, Theobald M, et al. Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia. N Engl J Med 2003;349: 743–752.
- Piccaluga PP, Martinelli G, Malagola M, et al. Complete remission in acute myeloid leukemia with granulocyte-colony stimulating factor without chemotherapy. Report of cytogenetic remission of a t(9;11) (p22q3) positive AML patient and review of literature. Haematologica 2003;88:ECR28.